Open AccessPerceived Institutional Barriers Among Clinical and Research Professionals: Minority Participation in Oncology Clinical Trials
Author(s) -
Soumya J. Niranjan,
Jennifer Wenzel,
Michelle Y. Martin,
Mo. Fouad,
Selwyn M. Vickers,
Badrinath R. Konety,
Raegan W. Durant
Publication year - 2021
Publication title -
jco oncology practice
Language(s) - English
Resource type - Journals
eISSN - 2688-1535
pISSN - 2688-1527
DOI - 10.1200/op.20.00970
Subject(s) - clinical trial , outreach , ethnic group , disadvantaged , medicine , institutional review board , clinical research , family medicine , political science , psychiatry , pathology , law
In general, participation rates in cancer clinical trials are very low. However, participation rates are especially low among the socially disadvantaged and racial and ethnic minority groups. These groups have been historically under-represented in cancer clinical trials. Although many patient-related barriers have been studied, institutional factors that are essential for building clinical research infrastructure around the clinical trial enterprise in academic medical centers have been underexplored.